Inventor · disambiguated record
Kuan-Chun Huang
Also filed as: HUANG KUAN-CHUN
10 granted patents·2 pending applications·66 citations·filing 2013–2025
88Inventor score
Top patents by PatentIndex Score
12 records- 0197US11491163B2Salt form of a human histone methyltransferase EZH2 inhibitorEPIZYME INC·Filed 2020·Granted Nov 8, 2022·6 cites·10 claims
- 0297US9394283B2Salt form of a human histone methyltransferase EZH2 inhibitorEPIZYME INC·Filed 2013·Granted Jul 19, 2016·27 cites·25 claims
- 0396US9872862B2Salt form of a human histone methyltransferase EZH2 inhibitorEPIZYME INC·Filed 2016·Granted Jan 23, 2018·14 cites·17 claims
- 0495US10821113B2Salt form of a human histone methyltransferase EZH2 inhibitorEPIZYME INC·Filed 2019·Granted Nov 3, 2020·6 cites·20 claims
- 0592US10245269B2Salt form of a human histone methyltransferase EZH2 inhibitorEPIZYME INC·Filed 2017·Granted Apr 2, 2019·8 cites·18 claims
- 0687US10246480B2Compounds for the treatment of cancerEISAI R&D MAN CO LTD·Filed 2018·Granted Apr 2, 2019·5 cites·30 claims
- 0783US12251386B2Salt form of a human histone methyltransferase EZH2 inhibitorEPIZYME INC·Filed 2022·Granted Mar 18, 2025·0 cites·35 claims
- 0878US2025268905A1Salt form of a human histone methyltransferase ezh2 inhibitorEPIZYME INC·Filed 2025·Application pending·0 cites
- 0969US11339188B2Compounds for the treatment of cancerEISAI R&D MAN CO LTD·Filed 2020·Granted May 24, 2022·0 cites·18 claims
- 1062US10618930B2Compounds for the treatment of cancerEISAI R&D MAN CO LTD·Filed 2019·Granted Apr 14, 2020·0 cites·18 claims
- 1158US2020055883A1Cyclic di-nucleotides derivative for the treatment of cancerEISAI R&D MAN CO LTD·Filed 2018·Application pending·0 cites
- 1254US12251394B2Methods for the treatment of bladder cancerEISAI R&D MAN CO LTD·Filed 2019·Granted Mar 18, 2025·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Kuan-Chun Huang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →